Article Details

Series B Boosts British Biotech's Cell Therapy Automation With €22.6M

Retrieved on: 2018-12-16 23:00:00

Tags for this article:

Click the tags to see associated articles and topics

Series B Boosts British Biotech's Cell Therapy Automation With €22.6M. View article details on hiswai:

Excerpt

<div>The round, led by Hong Kong-based investor <b>Horizons Ventures</b>, will help to fund the development of Synthace's software designed to automate key ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up